Surgical Outcomes in Fibromatosis: A Single-Centre Outcomes

Li, M., Cordon-Cardo, C., Gerald, W. L., & Rosai, J. (1996). Desmoid fibromatosis is a clonal process. Human Pathology, 27(9), 939–943.

Article  CAS  PubMed  Google Scholar 

Garcia-Ortega, D. Y., Martín-Tellez, K. S., Cuellar-Hubbe, M., Martínez-Said, H., Álvarez-Cano, A., Brener-Chaoul, M., et al. (2020). Desmoid-type fibromatosis. Cancers, 12(7), 1851.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., & Bonvalot, S. (2014). Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †. Annals of Oncology, 25, iii102–iii112.

Article  Google Scholar 

Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004). High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer, 100(3), 612–620.

Article  CAS  PubMed  Google Scholar 

Janinis, J., Patriki, M., Vini, L., Aravantinos, G., & Whelan, J. S. (2003). The pharmacological treatment of aggressive fibromatosis: A systematic review. Annals of Oncology, 14(2), 181–190.

Article  CAS  PubMed  Google Scholar 

Penel, N., Le Cesne, A., Bui, B. N., Perol, D., Brain, E. G., Ray-Coquard, I., et al. (2011). Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): An FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Annals of Oncology, 22(2), 452–457.

Article  CAS  PubMed  Google Scholar 

Kasper, B., Ströbel, P., & Hohenberger, P. (2011). Desmoid tumors: Clinical features and treatment options for advanced disease. The Oncologist, 16(5), 682–693.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonvalot, S., Eldweny, H., Haddad, V., Rimareix, F., Missenard, G., Oberlin, O., et al. (2008). Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. European Journal of Surgical Oncology (EJSO), 34(4), 462–468.

Article  CAS  PubMed  Google Scholar 

Eastley, N., Aujla, R., Silk, R., Richards, C. J., McCulloch, T. A., Esler, C. P., et al. (2014). Extra-abdominal desmoid fibromatosis—A sarcoma unit review of practice, long term recurrence rates and survival. European Journal of Surgical Oncology (EJSO), 40(9), 1125–1130.

Article  CAS  PubMed  Google Scholar 

Stoeckle, E., Coindre, J. M., Longy, M., Binh, M. B. N., Kantor, G., Kind, M., et al. (2009). A critical analysis of treatment strategies in desmoid tumours: A review of a series of 106 cases. European Journal of Surgical Oncology (EJSO), 35(2), 129–134.

Article  CAS  PubMed  Google Scholar 

Ghert, M., Yao, X., Corbett, T., Gupta, A. A., Kandel, R. A., Verma, S., et al. (2014). Treatment and follow-up strategies in desmoid tumours: A practice guideline. Current Oncology Toronto Ont, 21(4), e642-649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ballo, M. T., Zagars, G. K., Pollack, A., Pisters, P. W., & Pollack, R. A. (1999). Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. Journal of Clinical Oncology, 17(1), 158–167.

Article  CAS  PubMed  Google Scholar 

Salas, S., Dufresne, A., Bui, B., Blay, J. Y., Terrier, P., Ranchere-Vince, D., et al. (2011). Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: A wait-and-see policy according to tumor presentation. Journal of Clinical Oncology, 29(26), 3553–3558.

Article  PubMed  Google Scholar 

Zeng, W. G., Zhou, Z. X., Liang, J. W., Hou, H. R., Wang, Z., Zhou, H. T., et al. (2014). Prognostic factors for desmoid tumor: A surgical series of 233 patients at a single institution. Tumour Biology Journal of International Society of Oncodevelopmental Biology Medicine, 35(8), 7513–7521.

Article  CAS  Google Scholar 

Shido, Y., Nishida, Y., Nakashima, H., Katagiri, H., Sugiura, H., Yamada, Y., et al. (2009). Surgical treatment for local control of extremity and trunk desmoid tumors. Archives of Orthopaedic and Trauma Surgery, 129(7), 929–933.

Article  PubMed  Google Scholar 

Peng, P. D., Hyder, O., Mavros, M. N., Turley, R., Groeschl, R., Firoozmand, A., et al. (2012). Management and recurrence patterns of desmoids tumors: A multi-institutional analysis of 211 patients. Annals of Surgical Oncology, 19(13), 4036–4042.

Article  PubMed  PubMed Central  Google Scholar 

Goy, B. W., Lee, S. P., Eilber, F., Dorey, F., Eckardt, J., Fu, Y. S., et al. (1997). The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. International Journal of Radiation Oncology Biology Physics, 39(3), 659–665.

Article  CAS  PubMed  Google Scholar 

Micke O, Seegenschmiedt MH, German Cooperative Group on Radiotherapy for Benign Diseases. (2005). Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national Patterns of Care Study. International Journal of Radiation Oncology Biology Physics, 61(3), 882–891.

Article  Google Scholar 

Nuyttens, J. J., Rust, P. F., Thomas, C. R., & Turrisi, A. T. (2000). Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer, 88(7), 1517–1523.

Article  CAS  PubMed  Google Scholar 

Kindly check and update ref. [20].

Rydholm, A. (1997). Surgical margins for soft tissue sarcoma. Acta Orthopaedica Scandinavica, 68(sup273), 81–85.

Article  Google Scholar 

Fiore, M., Rimareix, F., Mariani, L., Domont, J., Collini, P., Le Péchoux, C., et al. (2009). Desmoid-type fibromatosis: A front-line conservative approach to select patients for surgical treatment. Annals of Surgical Oncology, 16(9), 2587–2593.

Article  PubMed  Google Scholar 

Crago, A. M., Denton, B., Salas, S., Dufresne, A., Mezhir, J. J., Hameed, M., et al. (2013). A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of Surgery, 258(2), 347–353. 2013 (4th) edition. Pathology (Phila). 2014 Feb;46(2):95–104.

Article  PubMed  PubMed Central  Google Scholar 

Merchant, N. B., Lewis, J. J., Woodruff, J. M., Leung, D. H., & Brennan, M. F. (1999). Extremity and trunk desmoid tumors: A multifactorial analysis of outcome. Cancer, 86(10), 2045–2052.

Article  CAS  PubMed  Google Scholar 

van Broekhoven, D. L. M., Verhoef, C., Elias, S. G., Witkamp, A. J., van Gorp, J. M. H. H., van Geel, Ba. N., et al. (2013). Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis. British Journal of Surgery, 100(9), 1214–1219.

Article  PubMed  Google Scholar 

Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., et al. (2017). An update on the management of sporadic desmoid-type fibromatosis: A European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology Official Journal of European Society For Medical Oncology, 28(10), 2399–2408.

Article  CAS  Google Scholar 

Bonvalot, S., Ternès, N., Fiore, M., Bitsakou, G., Colombo, C., Honoré, C., et al. (2013). Spontaneous regression of primary abdominal wall desmoid tumors: More common than previously thought. Annals of Surgical Oncology, 20, 4096–4102.

Article  PubMed  Google Scholar 

Ruspi, L., Cananzi, F. C., Sicoli, F., Samà, L., Renne, S. L., Marrari, A., Gennaro, N., Colombo, P., Cozzaglio, L., Politi, L. S., & Bertuzzi, A. (2021). Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach. European Journal of Surgical Oncology., 47(5), 1196–1200.

Article  PubMed  Google Scholar 

Shimizu, K., Hamada, S., Sakai, T., Koike, H., Yoshida, M., & Nishida, Y. (2020). Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: A systematic review. Japanese Journal of Clinical Oncology, 50(4), 419–424.

Article  PubMed  Google Scholar 

Kasper, B., Gruenwald, V., Reichardt, P., Bauer, S., Rauch, G., Limprecht, R., et al. (2017). Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). European Journal of Cancer, 76, 60–67.

Article  CAS  PubMed  Google Scholar 

Salas, S., Chibon, F., Noguchi, T., Terrier, P., Ranchere-Vince, D., Lagarde, P., et al. (2010). Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes, Chromosomes and Cancer, 49(6), 560–568.

Article  CAS  PubMed 

Comments (0)

No login
gif